PL3370698T3 - Kompozyty polimerowe zol-żel i ich zastosowania - Google Patents
Kompozyty polimerowe zol-żel i ich zastosowaniaInfo
- Publication number
- PL3370698T3 PL3370698T3 PL16805561T PL16805561T PL3370698T3 PL 3370698 T3 PL3370698 T3 PL 3370698T3 PL 16805561 T PL16805561 T PL 16805561T PL 16805561 T PL16805561 T PL 16805561T PL 3370698 T3 PL3370698 T3 PL 3370698T3
- Authority
- PL
- Poland
- Prior art keywords
- sol
- gel polymer
- polymer composites
- composites
- gel
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Reproductive Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Polymers & Plastics (AREA)
- Communicable Diseases (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562250126P | 2015-11-03 | 2015-11-03 | |
| US201662315756P | 2016-03-31 | 2016-03-31 | |
| PCT/US2016/060015 WO2017079216A1 (en) | 2015-11-03 | 2016-11-02 | Sol-gel polymer composites and uses thereof |
| EP16805561.4A EP3370698B1 (en) | 2015-11-03 | 2016-11-02 | Sol-gel polymer composites and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3370698T3 true PL3370698T3 (pl) | 2022-04-25 |
Family
ID=57471981
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16805561T PL3370698T3 (pl) | 2015-11-03 | 2016-11-02 | Kompozyty polimerowe zol-żel i ich zastosowania |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US10064870B2 (pl) |
| EP (1) | EP3370698B1 (pl) |
| JP (1) | JP6864001B2 (pl) |
| KR (1) | KR102145435B1 (pl) |
| CN (1) | CN108601723B (pl) |
| AU (1) | AU2016350868B2 (pl) |
| BR (1) | BR112018009010B1 (pl) |
| CA (1) | CA3002214C (pl) |
| CL (1) | CL2018001194A1 (pl) |
| ES (1) | ES2907686T3 (pl) |
| MX (1) | MX374683B (pl) |
| PL (1) | PL3370698T3 (pl) |
| PT (1) | PT3370698T (pl) |
| RU (1) | RU2761212C2 (pl) |
| UY (1) | UY36973A (pl) |
| WO (1) | WO2017079216A1 (pl) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201116559D0 (en) | 2011-09-26 | 2011-11-09 | Univ Leuven Kath | Novel viral replication inhibitors |
| JOP20160086B1 (ar) | 2015-05-08 | 2021-08-17 | 2 Katholieke Univ Leuven Ku Leuven Research And Development | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| JO3633B1 (ar) | 2015-09-16 | 2020-08-27 | Katholieke Univ Leuven Ku Leuven Research & Development | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| JOP20160198B1 (ar) | 2015-09-16 | 2022-03-14 | Janssen Pharmaceuticals Inc | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| CN109310705A (zh) * | 2016-03-18 | 2019-02-05 | 加拿大农业及农业食品部 | 干奶时加速乳腺退化和预防乳腺感染的方法 |
| WO2017167953A1 (en) | 2016-03-31 | 2017-10-05 | Janssen Pharmaceuticals, Inc. | Substituted indoline derivatives as dengue viral replication inhibitors |
| MX2018011784A (es) | 2016-03-31 | 2019-02-13 | Janssen Pharmaceuticals Inc | Derivados de indol sustituidos como inhibidores de la replicacion virica del dengue. |
| JOP20170069B1 (ar) | 2016-04-01 | 2021-08-17 | 1 Janssen Pharmaceuticals Inc | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| ES3010298T3 (en) | 2016-04-01 | 2025-04-02 | Janssen Pharmaceuticals Inc | Substituted indole compound derivatives as dengue viral replication inhibitors |
| US10406336B2 (en) | 2016-08-03 | 2019-09-10 | Neil S. Davey | Adjustable rate drug delivery implantable device |
| JOP20180026A1 (ar) | 2017-03-31 | 2019-01-30 | Univ Leuven Kath | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| JOP20180025B1 (ar) | 2017-03-31 | 2021-08-17 | Janssen Pharmaceuticals Inc | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| CN110536679B (zh) * | 2017-04-20 | 2023-03-31 | 硕腾服务有限责任公司 | 用于治疗乳腺炎的兽医用组合物和相关方法 |
| CA3060583C (en) | 2017-05-22 | 2024-06-04 | Janssen Pharmaceuticals, Inc. | Substituted indoline derivatives as dengue viral replication inhibitors |
| LT3630724T (lt) | 2017-05-22 | 2021-08-25 | Janssen Pharmaceuticals, Inc. | Pakeistieji indolino dariniai, kaip dengės viruso replikacijos inhibitoriai |
| CN110996903A (zh) * | 2017-06-09 | 2020-04-10 | 硕腾布鲁姆希尔Ip有限公司 | 乳房内兽用组合物 |
| CN109575484A (zh) * | 2017-09-29 | 2019-04-05 | 天津城建大学 | 新型埃洛石/聚乙烯醇复合气凝胶及其制备方法和应用 |
| CA3083607A1 (en) * | 2017-12-01 | 2019-06-06 | Zoetis Services Llc | Hydrogel compositions and uses thereof |
| CN111801068A (zh) * | 2018-01-18 | 2020-10-20 | 硕腾布鲁姆希尔Ip有限公司 | 内部乳头密封剂及其在预防干奶牛的牛乳腺炎中的应用 |
| EP3833362A4 (en) * | 2018-08-06 | 2022-05-18 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd | CELLULOSE-BASED TOPICAL FORMULATIONS |
| PH12021551172B1 (en) * | 2018-11-22 | 2023-09-15 | Univ Jichi Medical | Endoscope visual field-securing viscoelastic composition |
| EP3897134B1 (en) * | 2018-12-14 | 2025-01-08 | Ecolab USA Inc. | Stable iodine-containing antimicrobial teat dip compositions |
| CN110437471B (zh) * | 2019-07-11 | 2022-02-15 | 郑州轻工业学院 | 一种粘性复合水凝胶及其制备方法和用途 |
| JP2023507765A (ja) * | 2019-12-20 | 2023-02-27 | ベリ ナノ インコーポレイテッド | ナノ構造二成分ゲル組成物及びその使用 |
| CN111012947B (zh) * | 2019-12-30 | 2021-11-12 | 南京财经大学 | 一种可注射和自愈合淀粉基水凝胶及其制备方法和应用 |
| CN111214699A (zh) * | 2020-01-08 | 2020-06-02 | 广州贝奥吉因生物科技股份有限公司 | 一种用于周围神经损伤修复的水凝胶及其制备方法 |
| CN111840212B (zh) * | 2020-06-18 | 2023-07-21 | 余祖功 | 一种非人类动物用乳头封闭剂及其制备方法 |
| CN111825858B (zh) * | 2020-07-02 | 2023-04-25 | 南京师范大学 | 一种基于两性离子和角蛋白的复合水凝胶及其制备方法 |
| CN116157138A (zh) * | 2020-09-11 | 2023-05-23 | 联邦高等教育系统匹兹堡大学 | 源自细胞外基质的最终灭菌的水凝胶或胶体悬浮液的制备方法及其用途 |
| JP2024514853A (ja) * | 2021-04-09 | 2024-04-03 | コロラド・スクール・オブ・マインズ | ラジカル架橋双性イオンゲルおよびその使用 |
| WO2022229965A1 (en) * | 2021-04-28 | 2022-11-03 | Mileutis Ltd. | Compositions and methods for modulating mammary disorders and conditions |
| CN113736435B (zh) * | 2021-10-08 | 2023-05-12 | 扬州工业职业技术学院 | 一种钻井液用纳米微乳液封堵剂及其制备方法 |
| CN114539574B (zh) * | 2022-02-28 | 2023-06-06 | 浙江农林大学 | 压电-摩擦电耦合感应材料的制备方法和应用 |
| CN115990275A (zh) * | 2022-10-08 | 2023-04-21 | 江苏省人民医院（南京医科大学第一附属医院） | 一种黏膜下注射剂及其制备方法 |
| CN115645635A (zh) * | 2022-10-24 | 2023-01-31 | 杭州旸顺医疗科技有限公司 | 一种液相栓塞剂及其制备方法和用途 |
| CN115804870B (zh) * | 2022-12-02 | 2023-12-19 | 浙江大学 | 一种微创注射生物支架及其制造方法与应用 |
| CN120641108A (zh) * | 2022-12-06 | 2025-09-12 | 金珂生物医疗公司 | 抗溶解的可流动的壳聚糖生物粘附性止血组合物 |
| CN117362139A (zh) * | 2023-10-27 | 2024-01-09 | 湖北航天化学技术研究所 | 一种提高电控固体推进剂力学性能的方法 |
| WO2025160219A1 (en) * | 2024-01-23 | 2025-07-31 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Methods and compositions for treating reperfusion injury following myocardial infarction |
Family Cites Families (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4333484A (en) | 1978-08-02 | 1982-06-08 | Philip Morris Incorporated | Modified cellulosic smoking material and method for its preparation |
| DE69629010T2 (de) | 1995-01-16 | 2004-04-15 | Baxter International Inc., Deerfield | Selbsttragende flächengebilde aus vernetztem fibrin zur hemmung von postoperativen adhäsionen |
| CA2274796C (en) | 1996-12-18 | 2006-12-05 | Bimeda Research & Development Limited | Antiinfective free intramammary veterinary composition |
| CA2212300A1 (en) * | 1997-08-04 | 1999-02-04 | Abdellatif Chenite | In vitro or in vivo gelfying chitosan and therapeutic uses thereof |
| WO2001036000A1 (en) | 1999-11-15 | 2001-05-25 | Bio Syntech Canada, Inc. | Temperature-controlled and ph-dependant self-gelling biopolymeric aqueous solution |
| WO2001041821A1 (en) | 1999-12-09 | 2001-06-14 | Biosyntech Canada Inc. | Mineral-polymer hybrid composition |
| US20040047892A1 (en) | 2000-11-15 | 2004-03-11 | Desrosiers Eric Andre | Filler composition for soft tissue augmentation and reconstructive surgery |
| ATE473732T1 (de) | 2001-09-10 | 2010-07-15 | Bimeda Res And Dev Ltd | Biosicherheitssytem |
| KR100474945B1 (ko) | 2002-01-10 | 2005-03-10 | 알앤엘생명과학주식회사 | 젖소의 원유 중 체세포 감소용 및 유방염의 예방 또는치료용 조성물 |
| JP2007500692A (ja) * | 2003-07-31 | 2007-01-18 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | 乳房炎及び耳障害を治療するための分散性医薬組成物 |
| US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
| AU2005207684B2 (en) | 2004-02-02 | 2009-12-17 | Zoetis Broomhill Ip Limited | Method and device for treating a teat canal of an animal |
| US20050191270A1 (en) * | 2004-02-27 | 2005-09-01 | Hydromer, Inc. | Anti-infectious hydrogel compositions |
| CA2591942A1 (en) * | 2005-01-13 | 2006-07-20 | Cinvention Ag | Composite materials containing carbon nanoparticles |
| EP1845939A1 (en) * | 2005-02-03 | 2007-10-24 | Cinvention Ag | Drug delivery materials made by sol/gel technology |
| US9205046B2 (en) | 2005-04-25 | 2015-12-08 | The Governing Council Of The University Of Toronto | Enhanced stability of inverse thermal gelling composite hydrogels |
| US8323683B2 (en) | 2005-05-18 | 2012-12-04 | Mcneil-Ppc, Inc. | Flavoring of drug-containing chewing gums |
| WO2007066837A1 (en) | 2005-12-06 | 2007-06-14 | Lg Household & Health Care Ltd. | Delivery system for tooth whitening component using in situ gelling |
| WO2008005427A2 (en) | 2006-06-30 | 2008-01-10 | Biomimetic Therapeutics, Inc. | Pdgf-biomatrix compositions and methods for treating rotator cuff injuries |
| NZ549249A (en) | 2006-08-18 | 2009-10-30 | Univ Massey | Methods for reducing the incidence of mastitis by administration of keratin |
| CN103735574A (zh) | 2006-10-10 | 2014-04-23 | 威斯康星旧生研究基金会 | 乳房内乳头密封剂和使用该制剂降低或消除成熟干酪中视觉缺陷的方法 |
| AU2007355106A1 (en) | 2006-11-29 | 2008-12-18 | Foamix Ltd. | Foamable waterless compositions with modulating agents |
| US9034348B2 (en) | 2006-12-11 | 2015-05-19 | Chi2Gel Ltd. | Injectable chitosan mixtures forming hydrogels |
| JP5539727B2 (ja) * | 2006-12-11 | 2014-07-02 | チット２ジェル リミテッド | ヒドロゲルを形成する新規な注入可能なキトサン混合物 |
| US8153612B2 (en) | 2006-12-11 | 2012-04-10 | Chi2Gel Ltd. | Injectable chitosan mixtures forming hydrogels |
| EP2337544A2 (en) | 2007-04-30 | 2011-06-29 | Living Proof, Inc. | Use of matrix metalloproteinase inhibitors in skin care |
| CN101077377A (zh) * | 2007-05-09 | 2007-11-28 | 史义林 | 防治牛、羊乳房炎的复方碘化壳聚糖涂膜剂及其制备方法 |
| US20090081173A1 (en) | 2007-08-10 | 2009-03-26 | The Board Of Regents Of The University Of Texas System | Methods and compositions involving bacteriophage isolates |
| GB2459910B (en) * | 2008-04-21 | 2010-03-31 | Otonomy Inc | Controlled Release Corticosteroid Compositions and Methods for the Treatment of Otic Disorders |
| US8318817B2 (en) * | 2008-07-21 | 2012-11-27 | Otonomy, Inc. | Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
| US8962026B2 (en) * | 2008-09-26 | 2015-02-24 | The Regents Of The University Of Michigan | Nanoemulsion therapeutic compositions and methods of using the same |
| AU2009322372B2 (en) * | 2008-12-04 | 2014-09-25 | Boehringer Ingelheim Animal Health USA Inc. | Intramammary teat sealant |
| US20100172889A1 (en) * | 2008-12-05 | 2010-07-08 | Catchmark Jeffrey M | Degradable biomolecule compositions |
| CA2746699C (en) | 2008-12-16 | 2017-10-24 | Carlsberg A/S | Cellulose based polymer material |
| CN102316890A (zh) | 2008-12-19 | 2012-01-11 | 生物模拟治疗公司 | 具有降低的蛋白酶活性的骨移植物以及选择和使用的方法 |
| WO2011022070A2 (en) | 2009-08-20 | 2011-02-24 | The Regents Of The University Of California | Perivascular stem cell composition for bone |
| CN101664381A (zh) * | 2009-08-21 | 2010-03-10 | 天津生机集团股份有限公司 | 治疗奶牛乳房炎的原位凝胶缓释制剂的制备方法 |
| CN102125516B (zh) * | 2010-01-13 | 2014-03-26 | 北京大学 | 温敏型原位凝胶药物组合物 |
| US9301976B2 (en) | 2010-08-19 | 2016-04-05 | The Regents Of The University Of California | Compositions comprising perivascular stem cells and nell-1 protein |
| EP2651239A1 (en) | 2010-12-16 | 2013-10-23 | Spécialités Pet Food | Method for producing highly palatable dry cat food |
| GB201113606D0 (en) | 2011-08-05 | 2011-09-21 | Norbrook Lab Ltd | Dual chamber syringe |
| US20130108683A1 (en) | 2011-10-25 | 2013-05-02 | Biomimetic Therapeutics, Inc. | Compositions and methods for treating partial and full thickness wounds and injuries |
| WO2013062994A1 (en) | 2011-10-25 | 2013-05-02 | Biomimetic Therapeutics, Inc. | Compositions and methods for treating full thickness burn injuries |
| EP2917299A4 (en) | 2012-11-09 | 2016-06-29 | Bioastra Technologies Inc | NANOSTRUCTURED PHASE SWITCHING MATERIALS FOR SOLID WATER HEAT MANAGEMENT |
| RU2521401C1 (ru) * | 2012-12-07 | 2014-06-27 | ГНУ Краснодарский научно-исследовательский ветеринарный институт Российская академия сельскохозяйственных наук (Краснодарский НИВИ) | Средство для профилактики мастита у дойных коров в сухостойный период |
| JP6326601B2 (ja) | 2013-03-13 | 2018-05-23 | アンティース ソシエテ アノニム | 皮膚更新のためのペプチド及び前記ペプチドを使用する方法 |
| WO2014152959A1 (en) | 2013-03-14 | 2014-09-25 | Forsight Vision4, Inc. | Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant |
| CA2906938C (en) | 2013-03-15 | 2021-11-16 | Human Biomolecular Research Institute | Compounds and matrices for use in bone growth and repair |
| EP2968231B1 (en) * | 2013-03-15 | 2020-07-01 | Boehringer Ingelheim Animal Health USA Inc. | Antimicrobial polyamide compositions and mastitis treatment |
| TW201532621A (zh) | 2013-04-22 | 2015-09-01 | Neocutis Sa | 抗氧化劑組成物及其使用方法 |
| CN103381139A (zh) | 2013-05-10 | 2013-11-06 | 南京农业大学 | 黄芪多糖注射用原位凝胶及其制备方法 |
| AU2014318264B2 (en) | 2013-09-16 | 2018-10-04 | Zoetis Services Llc | Assembly for sequentially delivering substances, and associated methods |
| CN104510729A (zh) | 2013-09-26 | 2015-04-15 | 黄永 | 激活动物免疫抗性的脂肪酸及其衍生物的组合物 |
| WO2016054592A1 (en) | 2014-10-03 | 2016-04-07 | Cytori Therapeutics, Inc. | Use of regenerative cells in mitigating burn progression and improving skin graft incorporation and healing |
-
2016
- 2016-11-02 PL PL16805561T patent/PL3370698T3/pl unknown
- 2016-11-02 MX MX2018005547A patent/MX374683B/es active IP Right Grant
- 2016-11-02 RU RU2018115574A patent/RU2761212C2/ru active
- 2016-11-02 JP JP2018543015A patent/JP6864001B2/ja active Active
- 2016-11-02 PT PT168055614T patent/PT3370698T/pt unknown
- 2016-11-02 WO PCT/US2016/060015 patent/WO2017079216A1/en not_active Ceased
- 2016-11-02 US US15/341,028 patent/US10064870B2/en active Active
- 2016-11-02 KR KR1020187015258A patent/KR102145435B1/ko active Active
- 2016-11-02 CA CA3002214A patent/CA3002214C/en active Active
- 2016-11-02 BR BR112018009010-7A patent/BR112018009010B1/pt active IP Right Grant
- 2016-11-02 ES ES16805561T patent/ES2907686T3/es active Active
- 2016-11-02 EP EP16805561.4A patent/EP3370698B1/en active Active
- 2016-11-02 AU AU2016350868A patent/AU2016350868B2/en active Active
- 2016-11-02 CN CN201680064154.4A patent/CN108601723B/zh active Active
- 2016-11-03 UY UY0001036973A patent/UY36973A/es active IP Right Grant
-
2018
- 2018-05-03 CL CL2018001194A patent/CL2018001194A1/es unknown
- 2018-08-08 US US16/058,686 patent/US10729698B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US10729698B2 (en) | 2020-08-04 |
| BR112018009010B1 (pt) | 2023-09-26 |
| US20170119785A1 (en) | 2017-05-04 |
| KR20180075646A (ko) | 2018-07-04 |
| AU2016350868A1 (en) | 2018-05-10 |
| AU2016350868B2 (en) | 2022-03-31 |
| EP3370698A1 (en) | 2018-09-12 |
| RU2018115574A3 (pl) | 2020-03-13 |
| RU2761212C2 (ru) | 2021-12-06 |
| CL2018001194A1 (es) | 2019-05-17 |
| CN108601723B (zh) | 2022-05-17 |
| CA3002214A1 (en) | 2017-05-11 |
| WO2017079216A1 (en) | 2017-05-11 |
| US10064870B2 (en) | 2018-09-04 |
| CN108601723A (zh) | 2018-09-28 |
| UY36973A (es) | 2017-06-30 |
| BR112018009010A8 (pt) | 2019-02-26 |
| US20190030043A1 (en) | 2019-01-31 |
| CA3002214C (en) | 2022-01-04 |
| ES2907686T3 (es) | 2022-04-26 |
| BR112018009010A2 (pt) | 2018-10-30 |
| MX374683B (es) | 2025-03-04 |
| PT3370698T (pt) | 2022-03-02 |
| EP3370698B1 (en) | 2022-01-26 |
| KR102145435B1 (ko) | 2020-08-18 |
| JP2018536708A (ja) | 2018-12-13 |
| RU2018115574A (ru) | 2019-10-25 |
| MX2018005547A (es) | 2018-11-09 |
| JP6864001B2 (ja) | 2021-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3370698T3 (pl) | Kompozyty polimerowe zol-żel i ich zastosowania | |
| ZA201605858B (en) | Novel polysaccharide and uses thereof | |
| IL247014A0 (en) | 6-heteroaryloxy and 6-aryloxy-quinoline-2-carboxamides and their use | |
| SG11201702603RA (en) | Organosilica materials and uses thereof | |
| PL3152226T3 (pl) | Modyfikowane cyklopentapeptydy i ich zastosowania | |
| GB201503393D0 (en) | Polymers and uses thereof | |
| SG11201607082PA (en) | New tetracyano-anthraquino-dimethane polymers and use thereof | |
| ZA201801052B (en) | Combinations and uses thereof | |
| SMT202100585T1 (it) | Particelle di polimero e loro usi | |
| IL248014B (en) | Nanostructures and their applications | |
| EP3168250A4 (en) | Fluorine-atom-containing polymer and use thereof | |
| PL3158017T3 (pl) | Żywica, skład i zastosowanie | |
| GB2514927B (en) | Thiamethoxam and uses thereof | |
| IL254241A0 (en) | Etv2 and its uses | |
| IL254287A0 (en) | Cyclic galanin analogs and uses thereof | |
| SG10201501373WA (en) | Contrast Agent And Applications Thereof | |
| IL251518A0 (en) | Astaxanthin-based polymers and their uses | |
| GB2530711B (en) | Security composition and use thereof | |
| GB201813934D0 (en) | Thiamethoxam and uses thereof | |
| GB2545167B (en) | Cloches and use thereof | |
| HUP1500514A2 (en) | New ppv1 strain and uses thereof | |
| GB201513221D0 (en) | Silicone polymer blend composites | |
| PL3229772T3 (pl) | 6-arylo-9-glikozylopuryny i ich zastosowanie | |
| GB201413288D0 (en) | Silicone polymer blend composites | |
| GB201404728D0 (en) | Disc-over incorporating disc-heads and disc-earning |